phenoxybenzamine has been researched along with calmidazolium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekokoski, E; Törnquist, K | 1 |
| Escobar, E; Terrón, JA | 1 |
| Bellamy, TC; Garthwaite, J; Griffiths, CH; James, LR | 1 |
| Brouillette, WJ; Brown, GB; Zha, C | 1 |
4 other study(ies) available for phenoxybenzamine and calmidazolium
| Article | Year |
|---|---|
Inhibition of agonist-mediated calcium entry by calmodulin antagonists and by the Ca2+/calmodulin kinase II inhibitor KN-62. Studies with thyroid FRTL-5 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Barium; Biological Transport; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Calmodulin; Cell Line; Depression, Chemical; Fluphenazine; Imidazoles; Isoquinolines; Membrane Potentials; Phenoxybenzamine; Piperazines; Rats; Sulfonamides; Terpenes; Thapsigargin; Thyroid Gland | 1996 |
Amplifying effect of the selective calmodulin antagonist, calmidazolium, on the potency of nifedipine to inhibit alpha 1D-adrenoceptor-mediated contraction in the rat aorta.
Topics: Animals; Aorta, Thoracic; Calcium Channel Blockers; Calmodulin; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Phenoxybenzamine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Vasoconstrictor Agents; Vasodilator Agents | 2002 |
Inhibition of nitric oxide-activated guanylyl cyclase by calmodulin antagonists.
Topics: Animals; Calcium; Calmodulin; Cerebellum; Cyclic GMP; Guanylate Cyclase; Imidazoles; Inhibitory Concentration 50; Nitric Oxide; Nitric Oxide Donors; Phenoxybenzamine; Rats; Rats, Wistar; Signal Transduction; Trifluoperazine | 2009 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |